Cse bulletin: consolidation - bright minds biosciences inc. (drug)

Toronto, ontario--(newsfile corp. - le 12 juillet/july 2023) - bright minds biosciences inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every five (5) pre-consolidated common shares. as a result, the outstanding shares of the company will be reduced to approximately 3,772,071 common shares.

DRUG Ratings Summary

DRUG Quant Ranking